Inflammatory mediators in children with protein-energy malnutrition. 1997

R W Sauerwein, and J A Mulder, and L Mulder, and B Lowe, and N Peshu, and P N Demacker, and J W van der Meer, and K Marsh
Department of Medical Microbiology, University Hospital Nijmegen, Netherlands. R.Sauerwein@MMB.AZN.NL

Edema is a typical sign in kwashiorkor, which is present in a subset of patients with protein-energy-malnutrition (PEM). The pathophysiology of this edema is not well established. One of the abnormalities found in kwashiorkor is reduced concentrations of antioxidants, suggesting a compromised capacity to neutralize free radicals, which are known to induce tissue damage. We have studied plasma concentrations of several mediators of the inflammatory cascade. Concentrations of interleukin 6 (IL-6), C-reactive protein, and the soluble receptors of tumor necrosis factor alpha (sTNFR-p55 and sTNFR-p75) are greater in children with PEM, particularly in those with kwashiorkor, whereas soluble receptors of IL-6 (sIL6R-gp80) and IL-1 receptor antagonist concentrations are not significantly different from those of healthy children. In addition, concentrations of IL-6, sTNFR-p55, and sTNFR-p75 are greater in kwashiorkor patients irrespective of the presence of infection. Antioxidant status, as determined by plasma concentrations of glutathione and vitamin E, is significantly reduced in kwashiorkor patients. These data support the notion that children with edematous malnutrition show increased inflammatory reactivity that may contribute to edema formation.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007732 Kwashiorkor A syndrome produced by severe protein deficiency, characterized by retarded growth, changes in skin and hair pigment, edema, and pathologic changes in the liver, including fatty infiltration, necrosis, and fibrosis. The word is a local name in Gold Coast, Africa, meaning "displaced child". Although first reported from Africa, kwashiorkor is now known throughout the world, but mainly in the tropics and subtropics. It is considered to be related to marasmus. (From Dorland, 27th ed) Kwashiorkors
D011502 Protein-Energy Malnutrition The lack of sufficient energy or protein to meet the body's metabolic demands, as a result of either an inadequate dietary intake of protein, intake of poor quality dietary protein, increased demands due to disease, or increased nutrient losses. Marasmus,Protein-Calorie Malnutrition,Malnutrition, Protein-Calorie,Malnutrition, Protein-Energy,Malnutritions, Protein-Energy,Protein Calorie Malnutrition,Protein Energy Malnutrition
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005978 Glutathione A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. Reduced Glutathione,gamma-L-Glu-L-Cys-Gly,gamma-L-Glutamyl-L-Cysteinylglycine,Glutathione, Reduced,gamma L Glu L Cys Gly,gamma L Glutamyl L Cysteinylglycine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha

Related Publications

R W Sauerwein, and J A Mulder, and L Mulder, and B Lowe, and N Peshu, and P N Demacker, and J W van der Meer, and K Marsh
December 2002, Mediators of inflammation,
R W Sauerwein, and J A Mulder, and L Mulder, and B Lowe, and N Peshu, and P N Demacker, and J W van der Meer, and K Marsh
January 1980, Indian journal of pediatrics,
R W Sauerwein, and J A Mulder, and L Mulder, and B Lowe, and N Peshu, and P N Demacker, and J W van der Meer, and K Marsh
June 1983, Annals of tropical paediatrics,
R W Sauerwein, and J A Mulder, and L Mulder, and B Lowe, and N Peshu, and P N Demacker, and J W van der Meer, and K Marsh
March 1990, European journal of clinical nutrition,
R W Sauerwein, and J A Mulder, and L Mulder, and B Lowe, and N Peshu, and P N Demacker, and J W van der Meer, and K Marsh
December 1992, The West Indian medical journal,
R W Sauerwein, and J A Mulder, and L Mulder, and B Lowe, and N Peshu, and P N Demacker, and J W van der Meer, and K Marsh
January 1983, Journal of pediatric gastroenterology and nutrition,
R W Sauerwein, and J A Mulder, and L Mulder, and B Lowe, and N Peshu, and P N Demacker, and J W van der Meer, and K Marsh
September 1992, The Pediatric infectious disease journal,
R W Sauerwein, and J A Mulder, and L Mulder, and B Lowe, and N Peshu, and P N Demacker, and J W van der Meer, and K Marsh
October 1981, Hospital formulary,
R W Sauerwein, and J A Mulder, and L Mulder, and B Lowe, and N Peshu, and P N Demacker, and J W van der Meer, and K Marsh
February 1998, Journal of tropical pediatrics,
R W Sauerwein, and J A Mulder, and L Mulder, and B Lowe, and N Peshu, and P N Demacker, and J W van der Meer, and K Marsh
December 1984, Tropical and geographical medicine,
Copied contents to your clipboard!